ABCG1 and hepatocellular carcinoma: Furthermore, immunoblotting revealed that ABCG1 and the Wnt/β-catenin signaling pathway were both upregulated in HCC cell lines in the presence of continuous treatment with saracatinib or oxaliplatin.